Clinical Trial Update: Chemoradiotherapy of NSCLC Stage IIIB [Phase 2]

View source ↗

Summary

A Phase 2 trial of concomitant chemoradiotherapy for stage IIIB non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Intergroupe Francophone de Cancerologie Thoracique | Conditions: NSCLC Stage IIIB, Concomitant Radiochemotherapy | Phase 2 | Status: COMPLETED